Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The current evidence does not show any inherent performance-enhancing effect of GLP-1 agonists in healthy athletes if anything, the drugs side effects and impact on muscle/fueling could impair performance
Who likely does not need it: Young people with no cardiovascular risk factors and normal baseline lipids
References and Further Reading Pickart L
Available from: Accessed 9 Jun 2023 Aroda VR, Rosenstock J, Terauchi Y et al (2019) PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes
This is the primary driver of GLP-1 weight regain
Compounding pharmacies are regulated at a significantly lower standard
US$ 25.82
US$ 24.26
US$ 22.19
US$ 22.21
US$ 27.00
